AAPP Scientific Poster Session Abstracts
Currently Viewing Abstracts from 2007
2004 | 2005 | 2006 | 2007
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026
| Title | Presenter | Type | Session |
|---|---|---|---|
A Comparison of Mental Illness Prevalence and Treatment Patterns Between Foster and Non-Foster Children within the Texas Medicaid System
|
Original Research | ||
A Multi-Attribute Decision Making Model to Aid in the Selection of Mood Stabilizing Medications for the Treatment of Bipolar Disorder
|
Original Research | ||
A Retrospective Evaluation of Olanzapine and Risperidone Effects on Metabolic Factors in Children and Adolescents
|
Original Research | ||
A RETROSPECTIVE EVALUATION OF PHYSICIAN PRESCRIBING HABITS IN CHILDREN AND ADOLESCENTS WITH MENTAL RETARDATION AND BIPOLAR DISORDER
|
Work in Progress | ||
A review of the safety and tolerability of treatments for moderate to severe AD
|
Encore Presentation | ||
Ability to Manage Medication Regimen Affected by Depressive Symptoms and Medical Burden
|
Original Research | ||
ADHD SYMPTOM IMPROVEMENT IN CHILDREN TREATED WITH LISDEXAMFETAMINE DIMESYLATE: CGI
|
Encore Presentation | ||
Adverse drug events in the geriatric population as a result of potentially inappropriate medication prescribing
|
Work in Progress | ||
Agranulocytosis related to concurrent clozapine and peg-interferon therapy.
|
Therapeutic Case Management | ||
Anticholinergic effects of complex medication therapy regimens in chronically, severely, mentally ill patients at a state psychiatric health-care facility
|
Original Research | ||
Application of Pharmaceutical Care Principles in Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in a Community Mental Health Facility
|
Innovative Practices | ||
Appropriateness of Quetiapine Utilization in a 400-bed Community Hospital
|
Encore Presentation | ||
Aripiprazole augmentation in patients with severe and persistent mental illness
|
Original Research | ||
ARIPIPRAZOLE AUGMENTATION TO CLOZAPINE IN REFRACTORY SCHIZOPHRENIA
|
Work in Progress | ||
Aripiprazole-Induced Peripheral Edema: A Case Report
|
Therapeutic Case Management | ||
Assessment of Medication Management and Medication Education Groups in an Acute Psychiatric Facility
|
Work in Progress | ||
Association between the Methylenetetrahydrofolate Reductase (MTHFR) 677C/T Variant and Atypical Antipsychotic (AAPs) Associated Metabolic Syndrome and Insulin Resistance in Subjects with Schizophrenia
|
Original Research | ||
Atomoxetine For Children and Adolescents with ADHD and Reading Disorders
|
Encore Presentation | ||
Atomoxetine Treatment for ADHD: Young Adults Compared With Older Adults
|
Encore Presentation | ||
Augmentation of Aripiprazole with Low-Dose Clozapine
|
Therapeutic Case Management | ||
Bupropion Augmentation Versus Usual Care in the Treatment of Patients with Treatment-Resistant Depression
|
Encore Presentation | ||
Cardiac arrest secondary to amphetamine/dextroamphetamine abuse: a case report
|
Encore Presentation | ||
Cardiovascular monitoring of atypical antipsychotic pharmacotherapy in schizophrenia and bipolar spectrum disorders
|
Work in Progress | ||
Clozapine treatment in a patient with a persistently low neutrophil count
|
Therapeutic Case Management | ||
Clozapine Underutilization and Discontinuation in African-Americans Due to Leucopenia
|
Encore Presentation | ||
Comparative Safety and Tolerability of Alzheimer's Disease Treatments
|
Original Research | ||
Comparison of observed outcomes with intramuscular haloperidol, olanzapine, and ziprasidone for acute agitation in the emergency department
|
Work in Progress | ||
Complete Resolution of Olanzapine-Induced Diabetic Ketoacidosis
|
Encore Presentation | ||
Correlation of Anxiety with Depression and Quality of Life in People with Epilepsy: Symptomatic Improvement after Lamotrigine Adjunctive Therapy
|
Encore Presentation | ||
Demonstrating Proof of Principle and Finding the Right Dose: The Role of CSF ‘Dynabridging’ Studies
|
Encore Presentation | ||
DEVELOPMENT AND IMPLEMENTATION OF A PHARMACIST BASED DIABETES EDUCATION AND SELF-MANAGEMENT PROGRAM IN AN INPATIENT PSYCHIATRIC HOSPITAL
|
Innovative Practices | ||
Development and implementation of a pharmacist-run medication education program focusing on adherence to antipsychotic agents: a descriptive study
|
Work in Progress | ||
DEVELOPMENT OF A WEB-BASED CLINICIAN LEARNING PROGRAM FOR ALGORITHM-BASED CARE OF ADULTS WITH MAJOR MENTAL ILLNESSES: THE WEB-TEXAS MEDICAID ALGORITHM PROJECT (WEB-TMAP)
|
Innovative Practices | ||
Differential Antidepressant Symptom Efficacy: Placebo-controlled Comparisons of Duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram)
|
Original Research | ||
Does Gender Affect Valproate Pharmacokinetics?
|
Encore Presentation | ||
Early Symptom Change Prediction of Remission in Depression Treatment
|
Original Research | ||
ECONOMIC BURDEN OF ALCOHOLISM AND ALCOHOL ABUSE IN A US MANAGED-CARE SETTING
|
Original Research | ||
Effectiveness and tolerability of pregabalin for dystonia and other hyperkinetic movement disorders (HMDs): an open-label exploratory study
|
Encore Presentation | ||
Effects of Aripiprazole on Reproductive Endocrine Parameters
|
Encore Presentation | ||
Efficacy and safety of lacosamide in painful distal diabetic neuropathy
|
Original Research | ||
Efficacy and Safety of Rasagiline as adjunct therapy in Parkinson disease (PD) patients receiving levodopa and entacapone
|
Original Research | ||
Efficacy and Tolerability of Ropinirole in the Treatment of Restless Legs Syndrome (RLS)
|
Encore Presentation | ||
EFFICACY OF ACAMPROSATE IN PREVENTION OF SEVERE RELAPSE: ANALYSIS OF THE DATABASE FROM 16 CONTROLLED STUDIES
|
Encore Presentation | ||
Evaluation of an Inpatient Psychopharmacology Consult Service
|
Original Research | ||
Evaluation of Atypical Antipsychotic Polypharmacy in an Acute Inpatient Psychiatric Facility
|
Original Research | ||
Evaluation of Intramuscular Olanzapine Use for Acute Agitation in a General Medical Hospital
|
Work in Progress | ||
Evaluation of the Role of Family History in the Development of Diabetes Among Patients With Schizophrenia Receiving Clozapine or Olanzapine
|
Work in Progress | ||
First do not do harm. Drugs withdrawal in the management of a severely ill woman
|
Therapeutic Case Management | ||
Forensic Medication Usage Evaluations as Evidence of Treatment in a Patient's Best Medical Interest
|
Innovative Practices | ||
FORMULATION CONVERSION FROM DIVALPROEX SODIUM EC TO DIVALPROEX SODIUM ER: EFFECTS ON ADHERENCE
|
Work in Progress | ||
Frequency of CYP2D6, CYP2C19 and ABCB1 Variant Alleles in Treatment Sensitive and Treatment Resistant Psychiatric Patients
|
Work in Progress | ||
Functional, Clinical, and Economic Ramifications of Early Non-Response to Antipsychotics in the Naturalistic Treatment of Schizophrenia
|
Encore Presentation | ||
Galantamine Does Not Significantly Effect Positive or Negative Symptoms in Patients with Schizophrenia
|
Encore Presentation | ||
Genetic predictors of response to lithium in bipolar patients with euphoric and dysphoric mania: association to NTRK2, GRK3, and Bcl-2
|
Original Research | ||
Geriatric Depression Over the Decades: An evaluation of the incidence and treatment of depression in a geriatric primary care clinic
|
Work in Progress | ||
HEALTHCARE BURDEN OF PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME
|
Original Research | ||
Hypomania with Agitation Associated with Varenicline Use in Bipolar II Disorder
|
Therapeutic Case Management | ||
Impact of omega-3 fatty acid (fish oil) supplementation on the lipid panel of patients receiving atypical antipsychotics
|
Work in Progress | ||
Implementation of a Delirium Screening Protocol in an Intensive Care Unit in a Community Hospital: Incidence and Associated Outcomes
|
Original Research | ||
Implementation of Prescriber Profile Reports in a Community Mental Health Organization
|
Innovative Practices | ||
IMPROVEMENTS IN SYMPTOMS OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN SCHOOL-AGED CHILDREN WITH LISDEXAMFETAMINE DIMESYLATE AND EXTENDED-RELEASE MIXED AMPHETAMINE SALTS VERSUS PLACEBO IN A CLASSROOM ANALOG STUDY
|
Encore Presentation | ||
Incidence of Abnormal Metabolic Parameters and Weight Gain Induced by Atypical Antipsychotics in Elderly Dementia Patients
|
Work in Progress | ||
Increased Clozapine Concentration in a Patient with Pneumonia
|
Therapeutic Case Management | ||
INITIATIVES TO INCREASE PHARMACIST PARTICIPATION IN ADMISSION MEDICATION RECONCILIATION IN A PSYCHIATRIC ACUTE CARE INPATIENT UNIT
|
Innovative Practices | ||
LACK OF RASAGILINE – TYRAMINE INTERACTION IN LEVODOPA-NAIVE PATIENTS WITH PARKINSON DISEASE
|
Encore Presentation | ||
Long-Term Effects of Aripiprazole on the Lipid Profiles of Patients With Bipolar I Disorder
|
Encore Presentation | ||
Long-Term Safety and Efficacy of Memantine Treatment in Moderate to Severe Alzheimer’s Disease: Results from a Three-Year Trial
|
Encore Presentation | ||
Long-Term Symptomatic Remission in Schizophrenia Patients
|
Encore Presentation | ||
Long-term use of the rotigotine transdermal patch in early-stage Parkinson’s disease
|
Original Research | ||
Measuring The Improvement of Cognition in patients receiving clozapine ODT Using Positive and Negative Symptom Scale- A Pilot Study
|
Original Research | ||
Medication Use Evaluation of Risperidal Consta® in a VA outpatient mental health clinic
|
Original Research | ||
Metoclopramide-mediated hyperprolactinemia in a developmentally disabled adult woman: a case report
|
Therapeutic Case Management | ||
Multi-Step Approach to Educate Healthcare Workers on Antipsychotic Polypharmacy: Impact on Prescribing Practices
|
Innovative Practices | ||
Olanzapine-Fluoxetine Combination Versus Lamotrigine for Bipolar I Depression: Quality of Life Outcome Analysis
|
Encore Presentation | ||
Olanzapine-Induced Neutropenia: A Case Report
|
Therapeutic Case Management | ||
ONCE-DAILY DOSING, OVER A LARGE DOSE RANGE, IS APPROPRIATE FOR EXTENDED-RELEASE DIVALPROEX, BUT NOT FOR ENTERIC-COATED, DELAYED-RELEASE DIVALPROEX: EVIDENCE VIA COMPUTER SIMULATIONS AND IMPLICATIONS FOR EPILEPSY THERAPY
|
Encore Presentation | ||
PALIPERIDONE ER IN SCHIZOPHRENIA PATIENTS PREVIOUSLY RECEIVING RISPERIDONE
|
Original Research | ||
PALIPERIDONE EXTENDED-RELEASE IN PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY TREATED WITH ANTIPSYCHOTIC POLYPHARMACY
|
Original Research | ||
Personal Digital Assistant Based Pharmaceutical Care Consultation Documentation in a Regional State Psychiatric Facility
|
Innovative Practices | ||
Polypharmacy, Antipsychotic Dosage, and Discontinuation of Antipsychotic Therapy Among Patients with Bipolar Disorder
|
Original Research | ||
Post-Stroke Pseudobulbar Affect Treated with Dextromethorphan/Quinidine
|
Therapeutic Case Management | ||
PRE-SCREENING OF METABOLIC ABNORMALITIES AND HYPERTENSION AMONG PATIENTS WITH SERIOUS MENTAL ILLNESS AND CONCURRENT ANTIPSYCHOTIC THERAPY
|
Innovative Practices | ||
Predictors of Bipolar Disorder in Patients Diagnosed With Major Depression in a Privately Insured Population
|
Original Research | ||
Predictors of physiological response to mental stress in smokers
|
Original Research | ||
Prescribing Patterns in Children and Adolescents with Bipolar Disorder
|
Original Research | ||
Prevalence of erectile dysfunction among patients taking different antiepileptic medications
|
Work in Progress | ||
PREVALENCE OF INACCURATELY LABELED PSYCHOTROPIC ALLERGIES WITHIN A STATE PSYCHIATRIC FACILITY
|
Original Research | ||
RASAGILINE DOES NOT PROMOTE A TYRAMINE PRESSOR RESPONSE IN LEVODOPA-TREATED PATIENTS WITH PARKINSON DISEASE
|
Encore Presentation | ||
Rehospitalization Rates after Inpatient Discharge on Haloperidol Decanoate Compared to Risperidone Long-Acting Injection
|
Original Research | ||
Relationship of Supervision, Side Effects and Complexity to Adherence with Antipsychotic Treatment
|
Work in Progress | ||
Retrospective Review of Patients Treated for Depression Undergoing Gastric Bypass Surgery: A Focus on Medications
|
Work in Progress | ||
Ropinirole Improves Mood and Anxiety Symptoms in Patients with Restless Legs Syndrome (RLS)
|
Encore Presentation | ||
Safety of Rasgiline in Parkinson disease (PD) patients receiving serotonin reuptake inhibitors (SSRI)
|
Original Research | ||
Selegiline Transdermal System for the Treatment of Major Depressive Disorder: A Symptom-based Analysis of Placebo-Controlled Efficacy Trials
|
Encore Presentation | ||
Serotonin transporter promoter insertion/deletion subtypes, intron 2 VNTR, and Ile425 polymorphisms and SSRI-associated sexual dysfunction
|
Encore Presentation | ||
Sexual Dysfunction in Patients With Major Depressive Disorder: A Comparison Between Selegiline Transdermal System 6 mg/24 hr and Placebo Using a Patient-rated Scale
|
Encore Presentation | ||
Six-month rehospitalization rates of first-episode psychosis patients discharged on newer atypical antipsychotics versus olanzapine and risperidone
|
Work in Progress | ||
Steady State Concentrations after Standard and Higher Doses of Oral Olanzapine in Acutely Ill Patients with Schizophrenia or Schizoaffective Disorder with Suboptimal Prior Response
|
Encore Presentation | ||
Tamoxifen-exacerbated delusions: a case report
|
Therapeutic Case Management | ||
The biopharmaceutics of divalproex sodium extended-release tablets vs. other formulations: Top ten pharmacokinetic essentials for the clinician
|
Encore Presentation | ||
The long term metabolic effects of treatment with psychoactive medication in male children and adolescents: Baseline demographics
|
Original Research | ||
The misuse of fentanyl patch in a psychiatric patient
|
Encore Presentation | ||
The Pharmacogenomics of Antidepressant Tolerance
|
Work in Progress | ||
The Relationship Between Functional Outcomes and Treatment of Anxious and Painful Somatic Symptoms in Patients with Generalized Anxiety Disorder
|
Original Research | ||
TIME TO ONSET OF ACTIVITY AND RESPONSE ON INDIVIDUAL CAPS-SX17 ITEMS IN PATIENTS WITH POSTTRAUMATIC STRESS DISORDER TREATED WITH VENLAFAXINE XR: A POOLED ANALYSIS
|
Encore Presentation | ||
Tolerability of switching from an oral dopamine agonist to transdermal rotigotine in Parkinson’s disease
|
Original Research | ||
Transdermal Rotigotine: Evaluation of Efficacy and Continuous Drug Delivery in Parkinson’s Disease
|
Encore Presentation | ||
USE OF BUPROPION IN THE VETERAN POPULATION WITH POSTTRAUMATIC STRESS DISORDER
|
Original Research | ||
Utility of a CommunityZero Website to Enhance Communication During a Clinical Pharmacy Rotation
|
Encore Presentation | ||
Variability of Olanzapine Plasma Levels and the Influence of Drug Interactions
|
Work in Progress |